Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
J Acquir Immune Defic Syndr ; 90(S1): S206-S214, 2022 07 01.
Article in English | MEDLINE | ID: mdl-35703773

ABSTRACT

BACKGROUND: Given substance use disorders (SUDs) among people with HIV are highly prevalent, integrating SUD services within HIV service settings is needed to help end the HIV epidemic. In this study, we assessed the setting-intervention fit (SIF) of 9 evidence-based SUD interventions: acamprosate, disulfiram, oral naltrexone, injectable naltrexone, oral buprenorphine, injectable buprenorphine, contingency management, motivational interviewing, and cognitive behavioral therapy (CBT). SETTING: Clinical and nonclinical HIV service organizations (HSOs) in the United States. METHODS: In May 2020, a stakeholder-engaged real-time Delphi was completed with 202 HSOs. HSO respondents rated the extent to which each SUD intervention was fundable, implementable, retainable, sustainable, scalable, and timely for their HSO, and these 6 items were summed into an SIF score (possible range of 0-18). RESULTS: Motivational interviewing had the highest average SIF score (11.42), with SIF scores above the midpoint (9.5) for clinical (11.51) and nonclinical HSOs (11.36). For nonclinical HSOs, none of the other interventions were above the midpoint. For clinical HSOs, the average SIF scores were above the midpoint for CBT (10.97) and oral buprenorphine (9.51). Multivariate regression analyses, which controlled for characteristics of the HSO respondent, revealed geographic region of the United States and whether the HSO currently offered any substance use services as 2 of the best predictors of SIF scores. CONCLUSIONS: Notwithstanding the need to improve the SIF for the other evidence-based SUD interventions, motivational interviewing, CBT, and oral buprenorphine are currently the evidence-based SUD interventions with greatest perceived fit for integration within HSOs in the United States.


Subject(s)
Buprenorphine , HIV Infections , Substance-Related Disorders , Delphi Technique , Evidence-Based Medicine , HIV Infections/complications , HIV Infections/drug therapy , Humans , Naltrexone , Substance-Related Disorders/drug therapy , Substance-Related Disorders/therapy , United States/epidemiology
2.
AIDS Behav ; 26(4): 1183-1196, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34586532

ABSTRACT

Although HIV and substance use disorders (SUDs) constitute a health syndemic, no research to date has examined the perceived negative impacts of different SUDs for people with HIV (PWH). In May 2019, 643 stakeholders in the U.S., representing clients of AIDS service organizations (ASOs), ASO staff, and HIV/AIDS Planning Council members, participated in an innovative Stakeholder-Engaged Real-Time Delphi (SE-RTD) survey focused on the prevalence and individual-level negative impact of five SUDs for PWH. The SE-RTD method has advantages over conventional survey methods by efficiently sharing information, thereby reducing the likelihood that between-group differences are simply due to lack of information, knowledge, and/or understanding. The population-level negative impacts were calculated by weighting each SUD's individual-level negative impact on indicators of the HIV Care Continuum and other important areas of life by the perceived prevalence of each SUD. Overall, we found these SUDs to have the greatest population-level negative impact scores (possible range 0-24): alcohol use disorder (population-level negative impact = 6.9; perceived prevalence = 41.9%), methamphetamine use disorder (population-level negative impact = 6.5; perceived prevalence = 3.2%), and opioid use disorder (population-level negative impact = 6.4; perceived prevalence = 34.6%). Beyond further demonstration of the need to better integrate SUD services within HIV settings, our findings may help inform how finite funding is allocated for addressing the HIV-SUD syndemic within the U.S. Based on our findings, such future efforts should prioritize the integration of evidence-based treatments that help address use disorders for alcohol, methamphetamine, and opioids.


Subject(s)
Alcoholism , HIV Infections , Methamphetamine , Opioid-Related Disorders , Substance-Related Disorders , Alcoholism/epidemiology , HIV Infections/complications , HIV Infections/epidemiology , Humans , Opioid-Related Disorders/epidemiology , Prevalence , Substance-Related Disorders/complications , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy , United States/epidemiology
3.
Washington, D.C; American Council for the United Nations University; 1999. 340 p. tab.
Monography in English | PAHO | ID: pah-51196
4.
J Food Prot ; 40(9): 639-642, 1977 Sep.
Article in English | MEDLINE | ID: mdl-30736255

ABSTRACT

In recent years substantial attention has been given to environmental health and food protection in jails and prisons in the United States. As a result several commissions and task forces, as well as the courts, have studied conditions in the correctional setting which are hazardous to the health and well-being of inmates. This report, based on an investigation of 100 selected jails and prisons, summarizes findings on foodservice operations and their role in penal and correctional institutions.

SELECTION OF CITATIONS
SEARCH DETAIL
...